{"id":"W3132666517","doi":"10.1016/j.cgh.2021.02.025","title":"Five-Year Efficacy and Safety of Ustekinumab Treatment in Crohn’s Disease: The IM-UNITI Trial","year":2021,"lang":"en","type":"article","venue":"Clinical Gastroenterology and Hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":240,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Ustekinumab; Medicine; Adverse effect; Placebo; Internal medicine; Crohn's disease; Randomized controlled trial; Maintenance therapy; Dosing; Randomization; Clinical trial; Surgery; Disease; Chemotherapy; Adalimumab; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002945858,0.0001557542,0.0003719078,0.00002826868,0.00006941026,0.000006335035,0.0001086913,0.0002089818,0.00004097633],"category_scores_gemma":[0.0003272904,0.0001200351,0.0001217743,0.00002813961,0.0008383414,0.000003068223,0.0001885906,0.0001543368,0.000002689755],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000009549512,"about_ca_system_score_gemma":0.000167136,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000104881,"about_ca_topic_score_gemma":0.0006116428,"domain_scores_codex":[0.9978514,0.0008550227,0.0005458282,0.0004280435,0.00004644713,0.0002732578],"domain_scores_gemma":[0.9991297,0.0001725481,0.0001248162,0.0003645946,0.0000548465,0.0001535509],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.09725453,0.00052249,0.8997682,0.00002110443,0.0001327352,0.0006199295,0.00003425951,0.000005007452,0.00007872753,0.0003927752,0.0002017436,0.0009685326],"study_design_scores_gemma":[0.03638221,0.001131475,0.9603612,0.00001026981,0.0000915708,0.00004660067,0.0000625038,0.0000384764,0.0000264278,0.0001247025,0.001655626,0.00006893252],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978899,0.0004848483,0.00002880137,0.000893387,0.000236248,0.0003341138,0.00004761933,0.000004681313,0.00008036707],"genre_scores_gemma":[0.997322,0.001351653,0.00005970966,0.0008847593,0.0001428259,0.00003735198,0.00007306585,0.00001068238,0.0001180177],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06087232,"threshold_uncertainty_score":0.489489,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02035173540616127,"score_gpt":0.3085475369863828,"score_spread":0.2881958015802216,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}